BASIS OF PRESENTATION AND NATURE OF BUSINESS (Details Narrative) |
9 Months Ended |
---|---|
Sep. 30, 2023
USD ($)
Integer
| |
U.S. Patents owned by the company | 99 |
Expired patents | 53 |
Foreign patents owned by the company | 14 |
ILiAD Biotechnologies, LLC [Member] | |
Aggregate investment amount | $ | $ 7,000,000 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Number of entity's patents that another entity was found to have infringed. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all investments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|